Detalhe da pesquisa
1.
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Brain
; 146(11): 4633-4644, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369086
2.
Disability accrual in primary and secondary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(9): 707-717, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068931
3.
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.
J Neurol Neurosurg Psychiatry
; 94(12): 1004-1011, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414534
4.
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
Mult Scler
; 29(2): 221-235, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36433775
5.
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Mult Scler
; 29(7): 875-883, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851894
6.
Comparative effectiveness in multiple sclerosis: A methodological comparison.
Mult Scler
; 29(3): 326-332, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36800908
7.
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS.
Mult Scler
; 28(11): 1752-1761, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35373638
8.
Confirmed disability progression as a marker of permanent disability in multiple sclerosis.
Eur J Neurol
; 29(8): 2321-2334, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582938
9.
Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis.
Mult Scler
; 27(5): 755-766, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32538713
10.
Risk of secondary progressive multiple sclerosis: A longitudinal study.
Mult Scler
; 26(1): 79-90, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31397221
11.
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 90(4): 458-468, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30636699
12.
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
Brain
; 140(9): 2426-2443, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29050389
13.
Defining secondary progressive multiple sclerosis.
Brain
; 139(Pt 9): 2395-405, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27401521
14.
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.
J Neurol
; 271(1): 472-485, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768389
15.
Gerstmann-Sträussler-Scheinker syndrome with the P102L pathogenic mutation presenting as familial Creutzfeldt-Jakob disease: a case report and review of the literature.
Neurocase
; 19(1): 41-53, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-22494260
16.
The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
; 2023 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37114703
17.
Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries.
Mult Scler Relat Disord
; 76: 104803, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329786
18.
Is breastfeeding in MS harmful or not? An answer from real-world Czech data.
Mult Scler Relat Disord
; 76: 104790, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37348317
19.
A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry.
Neurodegener Dis Manag
; 13(4): 215-221, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37287269
20.
Predictors of treatment switching in the Big Multiple Sclerosis Data Network.
Front Neurol
; 14: 1274194, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38187157